Allscripts Healthcare Solutions (NASDAQ:MDRX) has earned an average recommendation of “Hold” from the twenty-five ratings firms that are presently covering the stock, AR Network reports. Twelve analysts have rated the stock with a hold rating and eight have issued a buy rating on the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $18.71.
A number of analysts have recently weighed in on MDRX shares. Analysts at Ned Davis Research upgraded shares of Allscripts Healthcare Solutions from a “sell” rating to a “neutral” rating in a research note on Monday, April 21st. Separately, analysts at Raymond James reiterated an “outperform” rating on shares of Allscripts Healthcare Solutions in a research note on Tuesday, April 15th. They now have a $19.00 price target on the stock. Finally, analysts at SunTrust initiated coverage on shares of Allscripts Healthcare Solutions in a research note on Friday, March 14th. They set a “buy” rating and a $22.50 price target on the stock.
Shares of Allscripts Healthcare Solutions (NASDAQ:MDRX) traded up 0.26% on Monday, hitting $15.64. 139,005 shares of the company’s stock traded hands. Allscripts Healthcare Solutions has a one year low of $12.54 and a one year high of $19.68. The stock’s 50-day moving average is $17.65 and its 200-day moving average is $16.14. The company’s market cap is $2.800 billion.
Allscripts Healthcare Solutions (NASDAQ:MDRX) last released its earnings data on Thursday, February 20th. The company reported $0.08 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $0.08. The company had revenue of $351.00 million for the quarter, compared to the consensus estimate of $343.47 million. On average, analysts predict that Allscripts Healthcare Solutions will post $0.40 earnings per share for the current fiscal year.
Allscripts Healthcare Solutions, Inc (NASDAQ:MDRX) is a provider of clinical, financial, connectivity and information solutions and related professional services to hospitals, physicians and post-acute organizations.
Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.